Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
6.55    0.00 (0.00%)
Bid:
6.20
Ask:
6.90
Spread: 0.70 (11.29%)
Market Cap: £70.42m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

SuperMeat Update

21 Mar 2024 17:40

RNS Number : 8653H
Agronomics Limited
21 March 2024
 

21 March 2024

 Agronomics Limited

("Agronomics" or the "Company")

SuperMeat's LCA Highlights a 47% Decrease in Carbon Footprint in Comparison to Conventional Chicken Production

 

Agronomics (LSE: ANIC), a leading listed company focused on the field of cellular agriculture, is pleased to announce that its portfolio company SuperMeat The Essence of Meat Ltd ("SuperMeat"), focused on the production of high-quality cultivated chicken, has announced the conclusions from a Life Cycle Assessment ("LCA"), projecting a carbon footprint 47% lower when compared to conventional chicken.

 

SuperMeat's LCA was conducted by CE Delft, an independent sustainability research and consultancy firm, to evaluate the anticipated environmental impact of large-scale production of SuperMeat's cultivated chicken, offering a glimpse into the future of sustainable meat production.

 

Assuming the integration of renewable energy sources and sustainable production processes for both cultivated and conventional methods, SuperMeat's cultivated chicken is projected to achieve a 47% lower carbon footprint, an 85% lessening in terrestrial acidification and a 90% cutback in land use compared to conventional chicken farming. The analysis also showed that even with reliance on standard grid electricity, SuperMeat's chicken could achieve a 27% reduction in the carbon footprint compared to conventional production.

 

Ido Savir, SuperMeat's CEO said:

 

"Efficiency in meat production is no longer a goal; it's a necessity. Our pilot plant is the proving ground for SuperMeat's vision of efficiency and sustainability. Through continuous production, we've showcased the potential to dramatically increase yields while reducing our environmental footprint, a testament to our dedication to advancing meat production."

 

Jim Mellon, Agronomics Executive Chairman commented:

 

"SuperMeat's Life Cycle Assessment sets an industry standard for the sustainable production of cultivated chicken. Chicken is already one of the most sustainable animal proteins which gives us confidence that the LCA metrics for pork and beef will be even more favourable. These results validate the place of cultivated meat as an imperative in the sustainable food production systems we seek to build."

 

For the full LCA findings, visit SuperMeat's website.

About SuperMeat

SuperMeat stands at the forefront of the cultivated meat sector, championing the move towards sustainable, nutritious, and animal-friendly meat production. The company has established a pivotal continuous process, setting a new standard in the production of cultivated meat. SuperMeat has formed strategic partnerships with leading food companies, underscoring its commitment to working together to create a better food system.

About Agronomics

Agronomics is a leading listed company focussing on investment opportunities within the field of cellular agriculture. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and ingredients with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability and address human health, food security, and animal welfare. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

For further information, please contact :-

 

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen

Giles Balleny

Michael Johnson

Charlie Combe

Lucy Williams

Charles Goodfellow

Bob Huxford Anthony Hughes

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

agronomics@secnewgate.co.uk

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFVDVTILFIS
Date   Source Headline
4th Feb 20257:00 amRNSNet Asset Value calculation as at 31 December 2024
30th Jan 20257:00 amRNSLiberation Labs Closes US$ 50.5 million Fundraise
21st Jan 20254:33 pmRNSFormo Secures a €35 million loan
24th Dec 202412:37 pmRNSFinal Results and Notice of AGM
13th Dec 20243:55 pmRNSExercise of Warrants, Total Voting Rights
28th Nov 20247:00 amRNSNet Asset Value calculation at 30 September 2024
27th Nov 20247:00 amRNS-RAll G Co Update
15th Oct 20244:36 pmRNSAgronomics invests US$ 2m in Liberation Labs
15th Oct 20247:00 amRNSAgronomics invests US$2m in Liberation Labs
10th Oct 20244:20 pmRNSJim Mellon – Director’s Dealing and PDMR
8th Oct 202411:30 amRNSJim Mellon – Director’s Dealing and PDMR
7th Oct 202411:52 amRNSExercise of Warrants & TVR
4th Oct 20241:57 pmRNSHolding(s) in Company
27th Sep 20247:00 amRNSShellbay Appoints New Chief Executive Officer
24th Sep 20249:00 amRNSMeatable awarded €7.6 million Innovation Credit
10th Sep 20247:00 amRNSFormo Closes a US$ 61 Million Series B Round
4th Sep 20247:00 amRNSGALY Raises US$ 33 Million in Series B Financing
8th Aug 20245:13 pmRNSHolding(s) in Company
8th Aug 20247:00 amRNSNAV Statement, Warrant Exercise, TVR
18th Jul 20247:00 amRNSOnego Bio Secures EUR 14 million in New Funding
17th Jul 20248:00 amRNSMeatly Receives Clearance for Cultivated Pet Food
6th Jun 20247:00 amRNSExercise of Warrants & TVR
29th May 20247:00 amRNSPortfolio Company Presentation – Clean Food Group
23rd May 20241:01 pmRNSMeatable Appoints Jeff Tripician as New CEO
7th May 20247:00 amRNSNet Asset Value calculation as at 31 March 2024
7th May 20247:00 amRNSMeatly Unveils Protein-Free Medium
26th Apr 20247:00 amRNSSolar Foods Raises an Additional EUR8 Million
22nd Apr 20247:00 amRNSAgronomics Newsletter
17th Apr 20247:00 amRNSMosa Meat Raises EUR 40 Million in New Financing
12th Apr 20247:00 amRNSExercise of Warrants
10th Apr 20249:30 amRNSPortfolio Company Presentation Series – Onego Bio
5th Apr 20247:00 amRNSAgronomics Invests US$10m in Liberation Labs
2nd Apr 20247:00 amRNSOnego Bio Raises EUR37 Million
26th Mar 20247:09 amRNSClean Food secures £2.5m additional funding
21st Mar 20245:40 pmRNSSuperMeat Update
20th Mar 202410:37 amRNSFormo Update
18th Mar 20247:00 amRNSMeatly Creates Cans of Cultivated Pet Food
13th Mar 20247:00 amRNSShiok Meats Merges with Umami Bioworks
21st Feb 20247:00 amRNSAgronomics Newsletter
14th Feb 20247:00 amRNSCalifornia Cultured Update
14th Feb 20247:00 amRNSUnaudited Interim Results
9th Feb 20247:00 amRNSNet Asset Value calculation as at 31 December 2023
8th Feb 202412:15 pmRNSResult of AGM
8th Feb 20247:00 amRNSPerformance Shares issued to Shellbay Investments
6th Feb 20247:00 amRNSBond Pet Foods Achieves Key Milestone
18th Jan 20247:00 amRNSIsraFirst Regulatory Approval for Cultivated Beef
10th Jan 202412:32 pmRNSAgronomics Newsletter
10th Jan 20247:00 amRNSExercise of Warrants and TVR
28th Dec 202312:36 pmRNSNew Website and Corporate Presentation
27th Dec 20231:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.